USPTO serial 98178380
CELMATIX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- VAN DEN ABEELEN, DEREK C
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CELMATIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New York, NY, US
New York, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron D. Hendelman
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the treatment and diagnosis of ovarian health diseases, conditions and disorders; pharmaceutical preparations for treating and diagnosing fertility-related conditions; fertility enhancement preparations; biomedical compounds being diagnostic preparations for clinical or medical use; reagents, enzymes, and biomarkers being diagnostic preparations for medical purposes | ACTIVE | — |
| 042 | pharmaceutical drug development services; data capture, analysis and reporting of clinical data in the field of women's health and ovarian health for the purpose of measuring and improving the quality of women's health care in the nature of scientific research; providing a web site featuring technology enabling women's health care providers to access resources related to women's health and ovarian health; scientific services, namely, providing scientific research information and performing research in the fields of women's health and medicine, ovarian health and medicine, and cancer treatment; scientific services, namely, conducting scientific research and analysis relating to outcomes research in women's health and cancer; providing temporary use of non-downloadable software for managing, gathering, generating, organizing, and sharing data in the fields of pharmaceutical development, medical clinical trials and medical research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 16, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 16, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 9, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 8, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 8, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 8, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 8, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 7, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 7, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 7, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 28, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 28, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 28, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 13, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 18, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 18, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 29, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 10, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 10, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 10, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 10, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 10, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 7, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 16, 2023 | NWAP | NEW APPLICATION ENTERED | — |